OHSONG PHARM, a company specializing in the export of pharmaceuticals to Japan, was selected as a ‘Small Giant Company of Korea’ in 2020.

The Small Giant Company Support Project aims to identify SMEs with innovation and growth potential, recognizing them as a “Export leading company”.

The Small Giant Company will receive the following benefits by 2023:

▲Export marketing services include activities like exhibitions, events, overseas sales assistance, and PR videos

▲Participation in domestic & international exhibitions, local buyer matchmaking consultation seminars, hosting overseas buyer domestic invitation meetings, and providing overseas  pre- and post-support  for overseas exhibitions, etc.

OHSONG PHARM was selected as a ‘Jeju Local Small Giant Company’ in 2018 and has continued to receive support from Jeju. In addition, OHSONG PHARM established Brio Pharma, a Japanese subsidiary, in 2017 to directly enter the Japanese pharmaceutical market.

This achievement contributed to OHSONG PHARM being selected as a 'Small Giant Company of Korea'.